BioCryst Pharmaceuticals 10K 2018 Annual report | BCRX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Achillion, agglutin, Akari, Alexion, Alnylam, amplification, amplifying, Analog, anemia, ankle, atypical, autoimmune, avacopan, bacterial, billed, billing, billion, biometric, biosimilar, body, Brazil, Brexit, bulk, category, cell, chain, ChemoCentryx, Chugai, circulate, classical, clear, commonly, deletion, denial, differentiation, dihydrochloride, dysregulation, eculizumab, endonuclease, Engl, England, essential, evolving, Excessive, exit, fracture, GDPR, grantor, harder, hemoglobinuria, hemolytic, IgA, incremental, instance, interaction, Journal, lectin, loop, mandatory, Med, membership, microbial, mild, myasthenia, nephropathy, NMO, nocturnal, nomenclature, Nonemployee, notification, optica, organizational, paroxysmal, PDMA, peptide, persist, PNH, Ra, ravulizumab, referenda, refinanced, rejection, role, runway, salt, SOC, standalone, summer, summing, Takeda, takhzyro, timepoint, topline, tranche, unaudited, unbilled, uncontrolled, uremic, warm, XII, Xofluza, zilucoplan

Removed: adult, advocacy, allocating, antisense, approximate, Army, assigned, avoralstat, BESP, BID, block, bona, bonafide, Budget, buyer, categorized, cGCP, cGLP, channel, Cohen, cohort, combined, commenced, comparing, counsel, declared, deliverable, depicting, designing, determinable, distributor, Erck, explore, Externally, featured, fide, finalized, Fred, Gilead, highest, hospitalized, IMA, infected, inpatient, interference, interval, involvement, low, macaque, Mapp, MLHW, negotiated, NHP, onlineNature, organization, passed, Patel, persuasive, pharmacodynamic, Phil, prekallikrein, preliminary, primate, projected, prolongation, publication, qualified, quantity, ratably, rebate, regimen, reliably, reversed, RNAi, Sanj, score, seller, shifted, Simplifying, sourced, South, streamlined, survived, timeframe, title, TPE, unrestricted, USAMRIID, vitro, ZMapp

Subsidiary		Jurisdiction of Incorporation
JPR Royalty Sub LLC		Delaware
MDCP, LLC		Delaware

BioCryst Pharmaceuticals (BCRX) 10-K2018 FY Annual report

Content analysis